Loading...
CD57(+) CD4 T cells underlie belatacept-resistant allograft rejection
Belatacept is a B7-specific fusion protein used to prevent allograft rejection by blocking T cell costimulation. Generally efficacious, it fails to prevent acute rejection in a sizable minority of patients. In experimental models, memory T cells mediate costimulation blockade-resistant rejection (Co...
Na minha lista:
| Udgivet i: | Am J Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4867077/ https://ncbi.nlm.nih.gov/pubmed/26603381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.13613 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|